Presented by Dr. Omid Hamid, Director of the Melanoma Center at The Angeles Clinic and Research Institute, this webinar reviews late breaking news, key takeaways, clinical data and other updates presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting that took place in June 2017 in Chicago, Illinois.
Dr. Hamid will share his key insights into what the landscape of melanoma treatment looks like for the near future. As Director of the Melanoma Center at The Angeles Clinic and Research Institute, Dr. Omid Hamid works to ensure that patients receive access to the most up-to-date therapeutics, based on molecular pathways of melanoma progression. Most recently, in his role with the Phase 1 Developmental Therapeutics Program, Dr. Hamid has been instrumental in bringing new therapies from the investigational lab to the clinic for patient benefit. These therapies involve immunological therapies such as PD-1 inhibitors, therapies against tumor angiogenesis, and targeted agents that block internal processes in tumor cell’s function.